Fangzheng Securities: The selection model for supermarkets is rapidly developing. Attention is drawn to the supply chain of high-quality leaders in the CSI SWS Food & Beverage index.

Currently, the growth rate of online traffic is slowing down, while offline stores are regaining some customer flow, among which, the share of traditional key account hypermarkets is rapidly decreasing, while the selection model supermarkets are beginning to flourish.

Zhitong FinanceDec 16, 2024 10:26

Sirio pharma (300791): Revenue maintains high growth and profitability indicators have improved significantly.

Investment highlights: Revenue maintains high growth, but the growth rate has narrowed. In the third quarter of 2024, the company achieved revenue of 1.058 billion yuan, a year-on-year increase of 10.43%, with the growth rate narrowing by 31.12 and 12.86 compared to the same period last year and the previous quarter, respectively.

central china securitiesDec 6, 2024 19:42

Express News | Sirio Pharma plans to invest in building a production base in Thailand.

BreakingsNov 28, 2024 20:06

Express News | Today, a total of 64 individual stocks in the A-share market experienced block trades, with Minsheng Bank, Shaanxi Coal Industry, and SAIC Motor Group leading in transaction volume.

BreakingsNov 25, 2024 20:38

Sirio Pharma (300791): Channel structure adjustment hinders the pace of business in China, but the long-term trend of optimizing leading pattern remains unchanged.

The event describes Sirio Pharma's announcement of the third quarter report for 2024. The company's total operating income for Q1-3 2024 is 3.048 billion yuan (+21.8% year-on-year); net income attributable to the parent company is 0.24 billion yuan (+29.52% year-on-year), after deducting non-recurring items.

Changjiang SecuritiesNov 4, 2024 13:16

Sirio Pharma (605338): Leading ODM in health supplements, integrating internal and external growth.

In 2024, the third quarter income increased by 10.4% year-on-year. The total operating income for the first three quarters of 2024 reached 3.048 billion yuan, an increase of 21.80% year-on-year; achieving a net income attributable to the parent company of 0.24 billion yuan, an increase of 29.52% year-on-year.

guosen securitiesOct 30, 2024 15:11